Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy

J Zimmermann1, L Schramm, C Wanner

  • 1Department of Medicine, University of Würzburg, Germany.

Clinical Nephrology
|October 1, 1996
PubMed

Insights

Altered blood flow properties (hemorheology) are significantly linked to diabetic nephropathy in patients with type 1 diabetes. These changes, including increased plasma viscosity and erythrocyte aggregation, may worsen vascular complications.

Area of Science:

  • Endocrinology
  • Nephrology
  • Hematology

Background:

  • Patients with type 1 diabetes mellitus (IDDM), particularly those with albuminuria, face a high risk of macrovascular and microvascular complications.
  • Beyond established risk factors, altered hemorheology (blood flow properties) may contribute to these complications.

Purpose of the Study:

  • To evaluate hemorheological parameters and plasma protein composition in IDDM patients with varying degrees of nephropathy (none, incipient, and overt).
  • To investigate plasma levels of von Willebrand Factor (vWF) as an indicator of endothelial injury.

Main Methods:

  • Studied 58 IDDM patients categorized by albuminuria levels (N0, N1, N2).
  • Assessed plasma viscosity, erythrocyte aggregation, erythrocyte deformability, and plasma protein levels (fibrinogen, alpha 2-macroglobulin, haptoglobin, albumin).
  • Measured plasma vWF levels to estimate endothelial injury.

Main Results:

  • Patients with incipient and overt nephropathy showed increased fibrinogen, alpha 2-macroglobulin, and haptoglobin levels, with a decrease in serum albumin.
  • Erythrocyte aggregation, plasma viscosity, and erythrocyte rigidity were elevated, especially in overt nephropathy.
  • Erythrocyte aggregation correlated positively with fibrinogen and alpha 2-macroglobulin, and negatively with albumin.
  • Plasma viscosity correlated positively with fibrinogen and haptoglobin.
  • Von Willebrand Factor levels were higher in patients with overt nephropathy.

Conclusions:

  • Blood rheology is significantly altered in IDDM patients with nephropathy.
  • Elevated vWF suggests endothelial damage, while changes in viscosity and aggregation may stem from altered plasma proteins due to proteinuria.
  • These hemorheological abnormalities could exacerbate microvascular and macrovascular damage in type 1 diabetes with nephropathy.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...